1 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
2 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
3 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
4 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
5 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
6 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
7 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
8 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
9 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
10 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-01699 |
D.Del. |
|
|
|
|
11 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00202 |
N.D.W.Va. |
|
|
|
|
12 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
13 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
14 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
15 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
16 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
17 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
18 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
19 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
20 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
21 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
22 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
23 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
24 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
25 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
26 |
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-02749 |
D.N.J. |
|
|
|
|
27 |
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-02749 |
D.N.J. |
|
|
|
|
28 |
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-02749 |
D.N.J. |
|
|
|
|
29 |
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-02749 |
D.N.J. |
|
|
|
|
30 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
31 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
32 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
33 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|
34 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|
35 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al |
3:15-cv-05982 |
D.N.J. |
|
|
|
- MSN Laboratories Private Limited
- Sun Pharma Global FZE
- Huahai US Inc.
- Zydus Pharmaceuticals (USA) Inc.
- 1149336 Ontario Inc.
- Aurobindo Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddys Laboratories, Ltd.
- Dr. Reddys Laboratories, Inc.
- InvaGen Pharmaceuticals Inc.
- Solco Healthcare US, LLC
- Mylan, Inc.
- Aurobindo Pharma Ltd.
- HEC Pharm Group
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Mylan Laboratories Limited
- Prinston Pharmaceutical Inc.
- Trustees of Tufts College
- Intas Pharmaceuticals Limited
- Accord Healthcare, Inc.
- HEC Pharm Group
- ASSIA CHEMICAL INDUSTRIES LTD.
- Sun Pharmaceutical Industries, Inc.
- HEC Pharm Group
- Teva Pharmaceuticals USA, Inc.
- Sun Pharmaceutical Industries Ltd.
- Cadila Healthcare Ltd.
- Tufts Medical Center
- PHV JASON Z. PESICK
- Mylan Pharmaceuticals, Inc.
- MSN Pharmaceuticals, Inc.
|
36 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al |
3:15-cv-05982 |
D.N.J. |
|
|
|
- MSN Laboratories Private Limited
- Sun Pharma Global FZE
- Huahai US Inc.
- Zydus Pharmaceuticals (USA) Inc.
- 1149336 Ontario Inc.
- Aurobindo Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddys Laboratories, Ltd.
- Dr. Reddys Laboratories, Inc.
- InvaGen Pharmaceuticals Inc.
- Solco Healthcare US, LLC
- Mylan, Inc.
- Aurobindo Pharma Ltd.
- HEC Pharm Group
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Mylan Laboratories Limited
- Prinston Pharmaceutical Inc.
- Trustees of Tufts College
- Intas Pharmaceuticals Limited
- Accord Healthcare, Inc.
- HEC Pharm Group
- ASSIA CHEMICAL INDUSTRIES LTD.
- Sun Pharmaceutical Industries, Inc.
- HEC Pharm Group
- Teva Pharmaceuticals USA, Inc.
- Sun Pharmaceutical Industries Ltd.
- Cadila Healthcare Ltd.
- Tufts Medical Center
- PHV JASON Z. PESICK
- Mylan Pharmaceuticals, Inc.
- MSN Pharmaceuticals, Inc.
|
37 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al |
3:15-cv-05982 |
D.N.J. |
|
|
|
- MSN Laboratories Private Limited
- Sun Pharma Global FZE
- Huahai US Inc.
- Zydus Pharmaceuticals (USA) Inc.
- 1149336 Ontario Inc.
- Aurobindo Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddys Laboratories, Ltd.
- Dr. Reddys Laboratories, Inc.
- InvaGen Pharmaceuticals Inc.
- Solco Healthcare US, LLC
- Mylan, Inc.
- Aurobindo Pharma Ltd.
- HEC Pharm Group
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Mylan Laboratories Limited
- Prinston Pharmaceutical Inc.
- Trustees of Tufts College
- Intas Pharmaceuticals Limited
- Accord Healthcare, Inc.
- HEC Pharm Group
- ASSIA CHEMICAL INDUSTRIES LTD.
- Sun Pharmaceutical Industries, Inc.
- HEC Pharm Group
- Teva Pharmaceuticals USA, Inc.
- Sun Pharmaceutical Industries Ltd.
- Cadila Healthcare Ltd.
- Tufts Medical Center
- PHV JASON Z. PESICK
- Mylan Pharmaceuticals, Inc.
- MSN Pharmaceuticals, Inc.
|
38 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al |
3:15-cv-05982 |
D.N.J. |
|
|
|
- MSN Laboratories Private Limited
- Sun Pharma Global FZE
- Huahai US Inc.
- Zydus Pharmaceuticals (USA) Inc.
- 1149336 Ontario Inc.
- Aurobindo Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddys Laboratories, Ltd.
- Dr. Reddys Laboratories, Inc.
- InvaGen Pharmaceuticals Inc.
- Solco Healthcare US, LLC
- Mylan, Inc.
- Aurobindo Pharma Ltd.
- HEC Pharm Group
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Mylan Laboratories Limited
- Prinston Pharmaceutical Inc.
- Trustees of Tufts College
- Intas Pharmaceuticals Limited
- Accord Healthcare, Inc.
- HEC Pharm Group
- ASSIA CHEMICAL INDUSTRIES LTD.
- Sun Pharmaceutical Industries, Inc.
- HEC Pharm Group
- Teva Pharmaceuticals USA, Inc.
- Sun Pharmaceutical Industries Ltd.
- Cadila Healthcare Ltd.
- Tufts Medical Center
- PHV JASON Z. PESICK
- Mylan Pharmaceuticals, Inc.
- MSN Pharmaceuticals, Inc.
|
39 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
40 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
41 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
42 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
43 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
44 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
45 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
46 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
47 |
CELGENE CORPORATION v. HETERO LABS LIMITED et al |
2:17-cv-03387 |
D.N.J. |
|
|
|
|
48 |
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-03168 |
D.N.J. |
|
|
|
|
49 |
DAIICHI SANKYO COMPANY, LIMITED et al v. MATRIX LABORATORIES, LTD. et al |
2:08-cv-02752 |
D.N.J. |
|
|
|
|
50 |
DAIICHI SANKYO COMPANY, LIMITED et al v. MATRIX LABORATORIES, LTD. et al |
2:08-cv-02752 |
D.N.J. |
|
|
|
|